menu
    • menu

    Company profile for Jounce Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and may bring long lasting benefit to patients. We have assembled a highly experienced team of experts to advance our pipeline of immunotherapies with the goal of transforming the way cancer is treated.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Jounce TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    780 Memorial Drive Cambridge, MA 02139
    Telephone
    Telephone
    (857) 259-3840
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://jouncetx.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/jounce-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/JounceTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Atea rejects 'undervalued' offer from Concentra
    Atea rejects 'undervalued' offer from Concentra

    31 May 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/concentra-finds-latest-acquisition-harder-swallow-atea-rejects-undervalued-offer

    James Waldron FIERCE BIOTECH
    31 May 2023
    Share Share
    Atea confirms unsolicited cash proposal from Tang Capital’s Concentra
    Atea confirms unsolicited cash proposal from Tang Capital’s Concentra

    23 May 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/atea-confirms-unsolicited-cash-proposal-from-tang-capitals-concentra-the-shell-buying-jounce-therapeutics/

    Kyle LaHucik ENDPTS
    23 May 2023
    Share Share
    Concentra rebounds with a shot at COVID-19-focused Atea
    Concentra rebounds with a shot at COVID-19-focused Atea

    22 May 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/concentra-rebounds-jounce-buy-shot-covid-19-focused-atea

    Annalee Armstrong FIERCE BIOTECH
    22 May 2023
    Share Share
    Jounce Therapeutics Announces Closing of Tender Offer
    Jounce Therapeutics Announces Closing of Tender Offer

    03 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/04/2660993/0/en/Jounce-Therapeutics-Announces-Closing-of-Tender-Offer.html

    GLOBENEWSWIRE
    03 May 2023
    Share Share
    Termination of Proposed Business Combination of Jounce and Redx Pharma plc
    Termination of Proposed Business Combination of Jounce and Redx Pharma plc

    03 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/03/2639214/0/en/Termination-of-Proposed-Business-Combination-of-Jounce-Therapeutics-Inc-and-Redx-Pharma-plc.html

    GLOBENEWSWIRE
    03 Apr 2023
    Share Share
    Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs
    Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs

    28 Mar 2023

    // HEALTH ET

    https://health.economictimes.indiatimes.com/news/pharma/jounce-dumps-redx-pharma-for-acquisition-by-concentra-to-cut-84-per-cent-of-jobs/99052357#:~:text=The%20new%20Concentra%20deal%20also,Jounce%20said%20in%20a%20statement.

    HEALTH ET
    28 Mar 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search